Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!

Crit Care. 2019 Jan 9;23(1):5. doi: 10.1186/s13054-018-2297-1.

Authors

Patrick M Honore¹, David De Bels², Luc Kugener², Sebastien Redant², Rachid Attou², Andrea Gallerani², Herbert D Spapen³

Affiliations

¹ ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital, 4, Place Arthur Van Gehucthen, 1020, Brussels, Belgium. patrick.honore@chu-brugmann.be.
² ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital, 4, Place Arthur Van Gehucthen, 1020, Brussels, Belgium.
³ Ageing & Pathology Research Group, Vrije Universiteit Brussel, 101, Laarbeeklaan, 1070, Brussels, Belgium.

No abstract available

Publication types

Letter
Comment

MeSH terms

Ascorbic Acid*
Critical Illness*
Humans
Renal Dialysis
Renal Replacement Therapy

Substances

Ascorbic Acid